KOKarina Ostrovska

Karina Ostrovska

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Karina Ostrovska has a total of 15 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Assessing the impact of supervised interval training on cardiovascular autonomic neuropathy in type 2 diabetes patients

    by Laura Stirane, Karlis Stirans, Leonora Pahirko, Janis Mednieks, Karina Ostrovska, Aija Kļavina, Leo Selavo, Jelizaveta Sokolovska

    This post hoc analysis of the “Healthy walk” study evaluated the effect of interval walking training on cardiovascular autonomic neuropathy (CAN) in type 2 diabetes (T2D) patients. At baseline, 64 T2D patients underwent tilt table testing with autonomic reflex tests: heart rate responses to the Valsalva maneuver, deep breathing, and standing, and blood pressure responses to standing and sustained handgrip, using the Ewing score. Fifty‐six participants were allocated to an interval training (IT) group and control group. The IT group completed supervised interval walking training three times weekly for 60 min over 4 months, while the control group received physical activity education. Twenty‐four participants in the IT group and 30 in the control group completed the study. The primary endpoint of this post hoc analysis was the change in Ewing score. CAN was detected in 42 patients (66%), mean Ewing score of 2.7 ± 0.72. Those with CAN, 16 were in the IT group and 19 in the control group. Both groups showed a significant reduction in Ewing scores (IT: from 2.5 to 1.77, p = 0.003; control: from 2.72 to 1.91, p = 0.001). Interval walking training and physical activity education both reduce CAN severity in T2D patients.


  • Open Access

    Optimisation of bronchoalveolar lavage technique for isolating alveolar macrophages in mice

    by R. Dovhyi, M. Rudyk, T. Serhiichuk, Y. Yumyna, A. Dvukhriadkina, K. Ostrovska, N. Senchylo, L. Skivka

    Bronchoalveolar lavage (BAL) is a widely used technique to collect immune cells from the lungs, with alveolar macrophages (AMs) being the most prevalent cells in BAL fluid. AMs are vital for maintaining lung homeostasis and providing immune defence against airborne pathogens. However, in murine models, BAL procedures usually yield low numbers of AMs, thus limiting experimental design, especially when high cell counts are needed. Objective — to optimise the BAL technique in mice to maximise the collection of AMs. Materials and methods. Young and older BALB/c mice were used in the study. Bronchoalveolar lavage was performed following the method of Luckow and Lehmann (2021) with modifications. Statistical analysis was done using the Mann‑Whitney U test, with a significance level set at p<0.05. Results. Female BALB/c mice of different ages were chosen due to the frequency of their use as models of pulmonary diseases. A simplified method described by Luckow and Lehmann (2021), which avoids tracheotomy by using peroral cannula insertion, was employed. The protocol was modified by securing the cannula with a ligature to prevent BAL fluid leakage in older mice. To reduce mechanical stress on alveoli, a buffer volume of 0.6 mL was used, and the study compared two buffer variants: one at room temperature without EDTA, and another heated to 37°C with EDTA. The pre‑heated buffer with EDTA significantly increased BAL cell yields in all mice groups, confirming the importance of these optimisations for higher cell recovery. Conclusions. Our modified bronchoalveolar lavage protocol includes securing the trachea with a ligature to prevent BAL fluid leakage, reducing lavage volume to 0.6 mL to minimise lung damage, and using a 37°C solution with EDTA for improved AM recovery rates. Further studies are needed to explore the significance of other buffer components for BAL protocol optimisation, the possible age‑related differences in AM isolation in male BALB/c mice, and the strain‑specific features of the BAL technique.


  • Open Access

    COMPARATIVE ASSESSMENT OF THE IMPACT OF INTERFERONOGENIC PREPARATIONLARIFAN ON MONOCYTES FROM AGED C57BL/6 AND BALB/C MICE IN VITRO

    by Roman Dovhyi, Mariia Rudyk, Anastasiia Dvukhriadkina, Karina Ostrovska, Dace Pjanova

    Background. Blood monocytes play a crucial role in immunity as effector cells of innate immunity. However, they can also promote hyperinflammation, as was described in COVID-19. Many viral infections trigger hyperinflammation by inhibiting type I interferon synthesis, necessitating search of interferon-based or interferonogenic treatments like Larifan – bacteriophagederived dsRNA with interferonogenic and immunomodulatory properties. Global statistics indicate that viral infections, including SARS-CoV-2, as well as hyperinflammation occur more frequently in males, especially in the older age group, and significantly depends on genetically determined profile of immune reactivity. The aim of this study was a comparative assessment of the impact of Larifan on the metabolic profile of peripheral blood monocytes from aged male C57BL/6 and BALB/c mice in vitro. Methods. Male aged C57BL/6 and BALB/c mice were used in this study. Blood samples were collected from facial vein and treated with Larifan in vitro. Phagocytic activity, ROS production, and expression of phenotypic markers were assessed by flow cytometry. Only live monocytes were gated and included in the analysis. Data are presented as median and interquartile range (IQR). Statistical differences were calculated using Kruskal–Wallis test, with significance set at p < 0.05. Results. BALB/c mice showed a lower baseline phagocytic index than C57Bl/6, but phagocytosis percentages were comparable. Treatment with Larifan reduced the phagocytosis percentage in both strains, yet the phagocytic index rose in BALB/c mice after dsRNA exposure. ROS production was higher in C57Bl/6 mice, with Larifan reducing ROS levels significantly in both strains. CD80 baseline expression levels were higher in BALB/c, and dsRNA increased CD80-positive cells as well as decreased expression level of CD80 in BALB/c mice only. CD206 expression was lower in BALB/c but unaffected by Larifan, while dsRNA reduced both number of CD206-positive cells and CD206 levels in C57Bl/6 mice. Conclusions. The metabolic profile of monocytes differs between Th1-dominant C57Bl/6 and Th2-biased BALB/c mice, with higher baseline indicators in C57Bl/6 mice. Larifan treatment exerts anti-inflammatory effects by reducing ROS synthesis in both strains, with BALB/c mice also displaying increased phagocytosis and reduced antigen-presenting capability